Investors

Insider Transactions

Date Name Title Type Sorted Ascending Shares Traded Price Range
Mar 22, 2010 aberman michael s Officer Acquisition (Non Open Market) 10,000 n/a
Jul 30, 2014 brown michael s Director Acquisition (Non Open Market) 5,687 n/a
Jul 17, 2014 brown michael s Director Acquisition (Non Open Market) 14,662 n/a
Jul 30, 2014 brown michael s Director Acquisition (Non Open Market) 5,687 n/a
Mar 6, 2014 brown michael s Director Acquisition (Non Open Market) 2,700 n/a
Apr 9, 2010 brown michael s Director Acquisition (Non Open Market) 29,662 n/a
Apr 29, 2011 gilman alfred g Director Acquisition (Non Open Market) 20,000 n/a
Dec 23, 2008 gilman alfred g Director Acquisition (Non Open Market) 6,000 n/a
Jan 2, 2009 gilman alfred g Director Acquisition (Non Open Market) 2,000 n/a
Dec 3, 2012 goldberg murray a Officer Acquisition (Non Open Market) 14,500 n/a
Mar 25, 2014 goldstein joseph l Director Acquisition (Non Open Market) 10,000 n/a
Aug 14, 2013 goldstein joseph l Director Acquisition (Non Open Market) 5,000 n/a
May 20, 2013 goldstein joseph l Director Acquisition (Non Open Market) 4,000 n/a
Sep 20, 2011 goldstein joseph l Director Acquisition (Non Open Market) 10,000 n/a
Aug 11, 2008 goldstein joseph l Director Acquisition (Non Open Market) 3,000 n/a
Sep 9, 2013 landry robert e Officer Acquisition (Non Open Market) 5,000 n/a
Sep 1, 2011 larosa joseph j Officer Acquisition (Non Open Market) 10,000 n/a
Nov 20, 2007 roberts william Officer Acquisition (Non Open Market) 34,684 n/a
Aug 22, 2008 roberts william Officer Acquisition (Non Open Market) 24,102 n/a
Aug 28, 2008 roberts william Officer Acquisition (Non Open Market) 8,106 n/a
Showing 1-20 of 850 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43  See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)